Company intelligence / Profile preview

Vivunt Pharma

Ownership: Private
Development stage: Commercial

Overview

Vivunt Pharma is an international pharmaceutical group with over 30 years of experience. The company specializes in manufacturing high-quality medicines—particularly sterile oncology drugs—and provides contract development and manufacturing services globally. It operates three manufacturing sites with state-of-the-art facilities compliant with EMA and FDA standards. Its portfolio includes both branded OTC products and generic drugs for oncology, pain management, flu symptoms, coughs, allergies, and general health.

Therapeutic areas: OtherOncologyNeurologyInfectious Diseases
Modalities: Small moleculeSterile injectable (liquid vials, lyophilized vials)
Industry: Biotech

Beyond the preview

Go deeper on Vivunt Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vivunt Pharma.

Explore the full profile